← The Wire
GANXNasdaq
Gain Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1819411
Develops novel small molecule therapeutics for CNS, LSDs, metabolic, and oncology diseases using its Magellan™ platform
$72M
Market cap
$1.98
Last close
+13.1%
1D
+7.0%
5D
12.5M
Volume
Price · last 39 sessions+4.2%
May 4L $1.59 · H $2.02Jun 29
106
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
10-Q10-QMay 11, 202610-Q10-QNov 12, 202510-Q10-QAug 12, 202510-Q10-QMay 14, 202510-Q10-QNov 14, 202410-Q10-QAug 8, 202410-Q10-QMay 14, 202410-Q10-QNov 14, 202310-Q10-QAug 10, 202310-Q10-QMay 12, 202310-Q10-QNov 10, 202210-Q10-QAug 8, 202210-Q10-QMay 16, 202210-Q10-QNov 12, 202110-Q10-QAug 12, 202110-Q10-QMay 10, 2021
Similar companies
Comparable business profile · signals at a glance